Cargando…
Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy
Monoclonal antibodies (mAb) have been used as therapeutic agents for various diseases, and immunoglobulin G (IgG) is mainly used among antibody isotypes due to its structural and functional properties. So far, regardless of the purpose of the therapeutic antibody, wildtype IgG has been mainly used,...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Biotechnology and Bioengineering
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236339/ https://www.ncbi.nlm.nih.gov/pubmed/34220207 http://dx.doi.org/10.1007/s12257-020-0181-8 |
_version_ | 1783714516091011072 |
---|---|
author | Kang, Seung Hyun Lee, Chang-Han |
author_facet | Kang, Seung Hyun Lee, Chang-Han |
author_sort | Kang, Seung Hyun |
collection | PubMed |
description | Monoclonal antibodies (mAb) have been used as therapeutic agents for various diseases, and immunoglobulin G (IgG) is mainly used among antibody isotypes due to its structural and functional properties. So far, regardless of the purpose of the therapeutic antibody, wildtype IgG has been mainly used, but recently, the engineered antibodies with various strategies according to the role of the therapeutic antibody have been used to maximize the therapeutic efficacy. In this review paper, first, the overall structural features and functional characteristics of antibody IgG, second, the old and new techniques for antibody discovery, and finally, several antibody engineering strategies for maximizing therapeutic efficacy according to the role of a therapeutic antibody will be introduced. |
format | Online Article Text |
id | pubmed-8236339 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Korean Society for Biotechnology and Bioengineering |
record_format | MEDLINE/PubMed |
spelling | pubmed-82363392021-06-28 Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy Kang, Seung Hyun Lee, Chang-Han Biotechnol Bioprocess Eng Invited Review Paper Monoclonal antibodies (mAb) have been used as therapeutic agents for various diseases, and immunoglobulin G (IgG) is mainly used among antibody isotypes due to its structural and functional properties. So far, regardless of the purpose of the therapeutic antibody, wildtype IgG has been mainly used, but recently, the engineered antibodies with various strategies according to the role of the therapeutic antibody have been used to maximize the therapeutic efficacy. In this review paper, first, the overall structural features and functional characteristics of antibody IgG, second, the old and new techniques for antibody discovery, and finally, several antibody engineering strategies for maximizing therapeutic efficacy according to the role of a therapeutic antibody will be introduced. The Korean Society for Biotechnology and Bioengineering 2021-06-28 2021 /pmc/articles/PMC8236339/ /pubmed/34220207 http://dx.doi.org/10.1007/s12257-020-0181-8 Text en © The Korean Society for Biotechnology and Bioengineering and Springer 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Invited Review Paper Kang, Seung Hyun Lee, Chang-Han Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy |
title | Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy |
title_full | Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy |
title_fullStr | Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy |
title_full_unstemmed | Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy |
title_short | Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy |
title_sort | development of therapeutic antibodies and modulating the characteristics of therapeutic antibodies to maximize the therapeutic efficacy |
topic | Invited Review Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236339/ https://www.ncbi.nlm.nih.gov/pubmed/34220207 http://dx.doi.org/10.1007/s12257-020-0181-8 |
work_keys_str_mv | AT kangseunghyun developmentoftherapeuticantibodiesandmodulatingthecharacteristicsoftherapeuticantibodiestomaximizethetherapeuticefficacy AT leechanghan developmentoftherapeuticantibodiesandmodulatingthecharacteristicsoftherapeuticantibodiestomaximizethetherapeuticefficacy |